Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
>=5-<10
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
>=1-<5%
General Information
Version
8.15
Revision date
2024-09-08
Product name
Papanicolaou"s solution 1a Harris"
1.2.1 Relevant identified uses
In vitro diagnostic reagent, Reagent for analysis
1.2.2. Uses advised against
This product is not intended for consumer use.The product is being supplied under the TSCA R&D Exemption (40 CFR Section 720.36). It is the recipient’s responsibility to comply with the requirements of the R&D exemption. The product may not be used for a non-exempt commercial purpose under TSCA unless appropriate consent is granted in writing by MilliporeSigma
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H373
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Signal word
Danger
Hazard statements
H318 Causes serious eye damage. H373 May cause damage to organs (Kidney) through prolonged or repeated exposure if swallowed.
Precautionary statements
P260 Do not breathe mist or vapors. P280 Wear eye protection/ face protection. P305 + P351 + P338 + IF IN EYES: Rinse cautiously with water for several minutes. P310 Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P314 Get medical advice/ attention if you feel unwell. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Serious eye damage (Category 1), H318 Specific target organ toxicity - repeated exposure, Oral (Category 2), Kidney, H373 For the full text of the H-Statements mentioned in this Section, see Section 16.
